DAXOR CORPORATION

Insiders Daxor Corporation Nyse

Equities

DXR

US2394671034

Market Closed - Nyse Other stock markets 04:30:00 2024-07-12 pm EDT			5-day change	1st Jan Change
9.2 ^USD	+1.21%		+2.11%	-4.17%

Jul. 11	Daxor Corporation?s BVA-100? Blood Volume Diagnostic Expands to Three New Centers, Gains Traction Nationwide	CI
Jun. 05	Daxor Corporation Appoints John L. Jefferies as Chief Medical Officer	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Daxor Corporation Appoints John L. Jefferies as Chief Medical Officer	Jun. 05	CI
Daxor Corporation Appoints Caleb Desrosiers, JD, MPA to its Board of Directors	22-01-21	CI
Daxor Corp. Approves Annual Dividend, Payable on December 29, 2016; Names Michael Feldschuh as President and Chief Executive Officer on Permanent Basis	16-11-18	CI
Daxor Corporation Announces Executive Changes	16-09-23	CI
Daxor Corp. Appoints Michael Feldschuh as President and Chief Executive Officer on a Temporary Basis; Declares Increase in Dividend for 2015, Payable on December 29, 2015	15-12-10	CI
Daxor Corporation Appoints Lisa Quartley as its First SVP, Marketing and Commercial Development	15-09-02	CI
Daxor Corp Appoints Michael Feldschuh as Executive Vice President	14-12-18	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Our Free Content Help you Secure and Increase the Performance of Your Investments

Secure my Investments

fermer